These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35965441)

  • 1. Drug-induced severe liver injury due to
    Zhu L; Geng J; Xiao A
    J Biomed Res; 2022 May; 36(3):215-220. PubMed ID: 35965441
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
    Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
    BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Injury by the Traditional Chinese Medicine Hanshirento, Zenshikunshito, and Ninjin'yoeito in a Patient with Lung Cancer: Probable Causality Assessed by the Updated Roussel Uclaf Causality Assessment Method.
    Funakoshi H; Momo K; Kashima A; Ida H; Miyata Y; Sagara H; Sasaki T
    Integr Cancer Ther; 2021; 20():15347354211004734. PubMed ID: 33769124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zanubrutinib-induced liver injury: a case report and literature review.
    Atallah E; Wijayasiri P; Cianci N; Abdullah K; Mukherjee A; Aithal GP
    BMC Gastroenterol; 2021 May; 21(1):244. PubMed ID: 34051727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause.
    Bokan G; Glamočanin T; Mavija Z; Vidović B; Stojanović A; Björnsson ES; Vučić V
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herb induced liver injury by Xianling Gubao Tablets: A case assessed for causality using updated RUCAM and integrated evidence chain.
    Li C; Li Y; Bai Z; Wang J; Li G; Xiao X
    Chin Herb Med; 2024 Apr; 16(2):301-309. PubMed ID: 38706827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certolizumab-induced liver injury: as assessed for causality by the updated RUCAM.
    Shakhashiro M; Crasta R; Javed F
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37748817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole Induced Recurrent Acute Toxic Hepatitis: A Case Report.
    Bilgic Y; Yilmaz C; Cagin YF; Atayan Y; Karadag N; Harputluoglu MMM
    Acta Gastroenterol Belg; 2017; 80(2):309-311. PubMed ID: 29560698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced liver injury associated with dacomitinib: A case report.
    Wang X; Huang A; Lu Y; Gao S; Hu W; Cheng H
    Front Oncol; 2022; 12():979462. PubMed ID: 36185261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated herb-induced liver injury: a potential association with herbal artemisinin use as supported by the updated RUCAM.
    Mathavan A; Mathavan A; Krekora U; Daily K
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37142282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria.
    Ma CD; Faust D; Bonkovsky HL
    Mol Genet Metab Rep; 2023 Mar; 34():100946. PubMed ID: 36578356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM.
    Plüß M; Tampe D; Schwörer H; Bremer SCB; Tampe B
    Front Pharmacol; 2022; 13():966910. PubMed ID: 36059975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series.
    Nagral A; Adhyaru K; Rudra OS; Gharat A; Bhandare S
    J Clin Exp Hepatol; 2021; 11(6):732-738. PubMed ID: 34230786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
    Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
    Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herb-Induced Liver Injury by Ayurvedic Medicine With Severe Lactic Acidosis: A Case Report.
    Sharma DS; Ahmed A; Razak AA; Sharma P
    Cureus; 2023 Feb; 15(2):e34761. PubMed ID: 36909122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran.
    Lewis JH; Larrey D; Olsson R; Lee WM; Frison L; Keisu M
    Int J Clin Pharmacol Ther; 2008 Jul; 46(7):327-39. PubMed ID: 18793587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
    Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
    Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.